These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 9811723)

  • 1. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.
    Zufferey R; Dull T; Mandel RJ; Bukovsky A; Quiroz D; Naldini L; Trono D
    J Virol; 1998 Dec; 72(12):9873-80. PubMed ID: 9811723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A third-generation lentivirus vector with a conditional packaging system.
    Dull T; Zufferey R; Kelly M; Mandel RJ; Nguyen M; Trono D; Naldini L
    J Virol; 1998 Nov; 72(11):8463-71. PubMed ID: 9765382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-inactivating lentiviral vectors with U3 and U5 modifications.
    Iwakuma T; Cui Y; Chang LJ
    Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a self-inactivating lentivirus vector.
    Miyoshi H; Blömer U; Takahashi M; Gage FH; Verma IM
    J Virol; 1998 Oct; 72(10):8150-7. PubMed ID: 9733856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter interference mediated by the U3 region in early-generation HIV-1-derived lentivirus vectors can influence detection of transgene expression in a cell-type and species-specific manner.
    Ginn SL; Fleming J; Rowe PB; Alexander IE
    Hum Gene Ther; 2003 Aug; 14(12):1127-37. PubMed ID: 12908965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration.
    Logan AC; Haas DL; Kafri T; Kohn DB
    J Virol; 2004 Aug; 78(16):8421-36. PubMed ID: 15280451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes.
    Kung SK; An DS; Chen IS
    J Virol; 2000 Apr; 74(8):3668-81. PubMed ID: 10729143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
    Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
    Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.
    Céfaï D; Simeoni E; Ludunge KM; Driscoll R; von Segesser LK; Kappenberger L; Vassalli G
    J Mol Cell Cardiol; 2005 Feb; 38(2):333-44. PubMed ID: 15698840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication.
    Bahner I; Sumiyoshi T; Kagoda M; Swartout R; Peterson D; Pepper K; Dorey F; Reiser J; Kohn DB
    Mol Ther; 2007 Jan; 15(1):76-85. PubMed ID: 17164778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization.
    Hu P; Bi Y; Ma H; Suwanmanee T; Zeithaml B; Fry NJ; Kohn DB; Kafri T
    Gene Ther; 2018 Oct; 25(7):454-472. PubMed ID: 30190607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
    Wagner R; Graf M; Bieler K; Wolf H; Grunwald T; Foley P; Uberla K
    Hum Gene Ther; 2000 Nov; 11(17):2403-13. PubMed ID: 11096444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus vectors using human and simian immunodeficiency virus elements.
    White SM; Renda M; Nam NY; Klimatcheva E; Zhu Y; Fisk J; Halterman M; Rimel BJ; Federoff H; Pandya S; Rosenblatt JD; Planelles V
    J Virol; 1999 Apr; 73(4):2832-40. PubMed ID: 10074131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
    Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
    Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.
    Mochizuki H; Schwartz JP; Tanaka K; Brady RO; Reiser J
    J Virol; 1998 Nov; 72(11):8873-83. PubMed ID: 9765432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentivirus vector mobilization and spread by human immunodeficiency virus.
    Evans JT; Garcia JV
    Hum Gene Ther; 2000 Nov; 11(17):2331-9. PubMed ID: 11096438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging.
    Arya SK; Zamani M; Kundra P
    Hum Gene Ther; 1998 Jun; 9(9):1371-80. PubMed ID: 9650621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of multigene and regulated lentivirus vectors.
    Reiser J; Lai Z; Zhang XY; Brady RO
    J Virol; 2000 Nov; 74(22):10589-99. PubMed ID: 11044103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.